Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
LIM-0705
DRUG
2 trials
Sponsors
Limerick BioPharma
Conditions
Impaired Glucose Tolerance
Insulin Resistance
Phase 1
Investigation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LIM-0705 in Male Subjects With Impaired Glucose Tolerance
Withdrawn
NCT01093677
Limerick BioPharma
Impaired Glucose Tolerance
Start: 2010-03-31
End: 2010-07-31
Target: 30
Updated: 2010-06-08
Phase 2
Safety, Tolerability, PK, and PD of LIM-0705 in Subjects With Impaired Glucose Tolerance or Abnormal HOMA-IR
NCT01364155
Limerick BioPharma
Impaired Glucose Tolerance, Insulin Resistance
Start: 2011-05-31
End: 2011-08-31
Target: 50
Updated: 2011-06-02